| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | | 230 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / BUCCAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | | 2400 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | TABLET, EXTENDED RELEASE / ORAL | | 210 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | | 360 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | | 2 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / NASAL | | 5 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | | 840 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SOLUTION / ORAL | | 123 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | | 18 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | | 81 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | | 46 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | TABLET / ORAL | | 96 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | | 15 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LOTION / TOPICAL | | 211 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | | 9 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | | 268 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SUSPENSION / INTRAMUSCULAR | | 36 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | | 60 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | | 58 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / SUBCUTANEOUS | | 101 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | | 16734 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | | 25 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SUSPENSION / SOFT TISSUE | | 3 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | SOLUTION / ORAL | | 140 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | OINTMENT / TOPICAL | | 1 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | | 13 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | TROCHE / ORAL | 28 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE / ORAL | | 4 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | SOLUTION/ DROPS / TOPICAL | 0.14 %w/v | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | SOLUTION / INTRAVENOUS | | 381 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | AEROSOL, FOAM / TOPICAL | 0.09 %w/w | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | | 18144 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 48 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 139.2 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, EMULSION / INTRAVENOUS | 0.28 %w/v | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | | 750 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | | 42 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | | 1751 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SUSPENSION / INTRALESIONAL | | 3 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / INTRAVENOUS | | 2460 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium phosphate, dibasic, anhydrous | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | TABLET, FOR SUSPENSION / ORAL | | 60 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |